- Home
- CLLS vs VPV Comparison
CLLS vs VPV Comparison
Compare CLLS & VPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- VPV
- Stock Information
- Founded
- CLLS 1999
- VPV 1993
- Country
- CLLS France
- VPV United States
- Employees
- CLLS N/A
- VPV N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- VPV Trusts Except Educational Religious and Charitable
- Sector
- CLLS Health Care
- VPV Finance
- Exchange
- CLLS Nasdaq
- VPV Nasdaq
- Market Cap
- CLLS 240.2M
- VPV 261.9M
- IPO Year
- CLLS 2007
- VPV N/A
- Fundamental
- Price
- CLLS $1.87
- VPV $11.03
- Analyst Decision
- CLLS Buy
- VPV
- Analyst Count
- CLLS 3
- VPV 0
- Target Price
- CLLS $7.00
- VPV N/A
- AVG Volume (30 Days)
- CLLS 93.0K
- VPV 36.6K
- Earning Date
- CLLS 11-04-2024
- VPV 01-01-0001
- Dividend Yield
- CLLS N/A
- VPV 3.60%
- EPS Growth
- CLLS N/A
- VPV N/A
- EPS
- CLLS N/A
- VPV N/A
- Revenue
- CLLS $36,042,000.00
- VPV N/A
- Revenue This Year
- CLLS $271.02
- VPV N/A
- Revenue Next Year
- CLLS $33.48
- VPV N/A
- P/E Ratio
- CLLS N/A
- VPV N/A
- Revenue Growth
- CLLS 46.96
- VPV N/A
- 52 Week Low
- CLLS $1.70
- VPV $8.58
- 52 Week High
- CLLS $3.77
- VPV $10.28
- Technical
- Relative Strength Index (RSI)
- CLLS 47.58
- VPV 45.05
- Support Level
- CLLS $1.70
- VPV $10.87
- Resistance Level
- CLLS $2.00
- VPV $11.13
- Average True Range (ATR)
- CLLS 0.11
- VPV 0.07
- MACD
- CLLS 0.02
- VPV 0.01
- Stochastic Oscillator
- CLLS 56.67
- VPV 61.54
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About VPV Invesco Pennsylvania Value Municipal Income Trust (DE)
Invesco Pennsylvania Value Municipal Income Trust is a diversified, closed-end management investment company. The investment objective is to provide common shareholders with a high level of current income exempt from federal and Pennsylvania income taxes and, where possible under local law, local income and personal property taxes, consistent with preservation of capital.